Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Uzedy™ (risperidone) – New drug approval
April 28, 2023 - Teva Neuroscience and MedinCell announced the FDA approval of Uzedy (risperidone) subcutaneous injection, for the treatment of schizophrenia in adults.
